Ann Thorac Surg 2003;75:1412-1413
© 2003 The Society of Thoracic Surgeons
Original article: cardiovascular
Invited commentary
James R. Pluth, MDa
a Mayo Clinic13,400 East Shea BlvdScottsdale, AZ 85255, USA
e-mail: jrpluth@aol.com
| The first 20% of the full text of this article appears below. |
For the past 30 years, the use of arterial and venous conduits have provided not only symptomatic relief but have prolonged the life of millions of patients with atherosclerotic heart disease. In some instances, less than ideal results were achieved due in large part to poor distal runoff and small target vessels, but in general, these were considered the breaks of the game. In their paper, Kleikamp and colleagues present their long-term results on surgical revascularization on a select group of patients, namely those with ischemic cardiomyopathy. The surprising conclusion that the authors make is that poor coronary vessels represent an independent variable for patient selection and that patients with poor coronary vasculature, regardless of myocardial viability, . . . [Full Text of this Article]
Copyright © 2003 by The Society of Thoracic Surgeons.